Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1994 1
1995 1
1996 3
1997 3
1998 10
1999 3
2000 5
2001 5
2002 10
2003 9
2004 8
2005 11
2006 13
2007 11
2008 12
2009 13
2010 12
2011 14
2012 14
2013 12
2014 9
2015 9
2016 8
2017 11
2018 17
2019 16
2020 15
2021 22
2022 12
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: mossner r. Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Pharmacopsychiatry. 2018. PMID: 28910830 Free article. Review.
Biosimilars und Patientenversorgung.
Mössner R. Mössner R. J Dtsch Dermatol Ges. 2018 Feb;16(2):133-134. doi: 10.1111/ddg.13429_g. J Dtsch Dermatol Ges. 2018. PMID: 29418091 No abstract available.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: mossner r. Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. Pharmacopsychiatry. 2018. PMID: 29390205 No abstract available.
Dokumentation der Psoriasis in der Routineversorgung - Expertenkonsens zu einem deutschen Datensatz.
Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, Beiteke U, Bonnekoh B, Hoffmann M, Körber A, Maaßen D, Mössner R, Navarini A, Petering H, Ramaker-Brunke J, Rosenbach T, Schwichtenberg U, Sticherling M, Sondermann W, Thaci D, Timmel A, Tsianakas A, Werfel T, Wilsmann-Theis D, Augustin M. Otten M, et al. Among authors: mossner r. J Dtsch Dermatol Ges. 2021 Oct;19(10):1463-1477. doi: 10.1111/ddg.14547_g. J Dtsch Dermatol Ges. 2021. PMID: 34661349 German.
Severe side effects of targeted therapies.
Mössner R. Mössner R. J Dtsch Dermatol Ges. 2022 Jun;20(6):747-748. doi: 10.1111/ddg.14827. J Dtsch Dermatol Ges. 2022. PMID: 35711044 No abstract available.
267 results